Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Study Identifier
192024-051
CT.gov Identifier
NCT01064882
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • bimatoprost ophthalmic solution 0.005%
  • bimatoprost ophthalmic solution 0.015%
  • bimatoprost ophthalmic solution 0.03%
    • Phase
    Phase 2
    Sex
    Female
    Age
    30 - 55 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Female Caucasians between 30 and 55 years of age, with hypotrichosis (inadequate or not enough) of the eyelashes * Eyelash prominence assessment of minimal or moderate
    Exclusion Criteria:
    * Any eye disease or abnormality * Any permanent eyeliner or eyelash implants of any kind * Any ocular surgery, semi-permanent eyelash tint, or eyelash extension application during the 3 months prior to study entry * Any use of prescription eyelash growth products * Any use of over the counter eyelash growth products during the 6 months prior to baseline * Any use of treatments that may affect hair growth during the 6 months prior to baseline

    Protocol Summary

    This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence

    Study Locations

    Location
    Status
    Location
    San Diego, California, United States
    Status
    Not applicable